An Update on the Use of Disease-Modifying Therapy in Pregnant Patients with Multiple Sclerosis

Predictors of long-term disability accrual in relapse-onset multiple sclerosis

(2016) Vilija G. Jokubaitis et al.   ANNALS OF NEUROLOGY

Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study

(2016) Susan Friend et al.   BMC Neurology

The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis

(2016) Evelyn Brandt-Wouters et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Reversible cerebral vasoconstriction syndrome associated with interferon beta-1a use for multiple sclerosis

(2016) Tamara Strohm et al.   Multiple Sclerosis Journal

Glatiramer acetate during early pregnancy: A prospective cohort study

(2016) Sandra Herbstritt et al.   Multiple Sclerosis Journal

Interferon-beta exposure during first trimester is safe in women with multiple sclerosis—A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry

(2016) Sandra Thiel et al.   Multiple Sclerosis Journal

Natalizumab throughout pregnancy: Risk of low platelet count in the newborn at delivery

(2016) J. Ciron et al.   REVUE NEUROLOGIQUE

Pregnancy outcomes in Lebanese women with multiple sclerosis (the LeMS study): a prospective multicentre study

(2016) Jawad Fares et al.   BMJ Open

Reversible cerebral vasoconstriction syndrome associated with interferon beta-1a use for multiple sclerosis

(2016) Tamara Strohm et al.   Multiple Sclerosis Journal

Glatiramer acetate during early pregnancy: A prospective cohort study

(2016) Sandra Herbstritt et al.   Multiple Sclerosis Journal

Interferon-beta exposure during first trimester is safe in women with multiple sclerosis—A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry

(2016) Sandra Thiel et al.   Multiple Sclerosis Journal

Fertility, Pregnancy and Childbirth in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs

(2015) Maria Pia Amato et al.   CNS DRUGS

An overview of pregnancy-related issues in patients with multiple sclerosis

(2015) C. Pozzilli et al.   EUROPEAN JOURNAL OF NEUROLOGY

Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis

(2015) Aaron L Boster et al.   Expert Review of Neurotherapeutics

Transfer of Natalizumab into Breast Milk in a Mother with Multiple Sclerosis

(2015) Teresa E. Baker et al.   JOURNAL OF HUMAN LACTATION

Fecundity in women with multiple sclerosis: an observational mono-centric study

(2015) Thomas Roux et al.   JOURNAL OF NEUROLOGY

Natalizumab continuation during pregnancy in a patient with previous severe IRIS syndrome

(2015) M. Théaudin et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study

(2015) Maria Sepúlveda et al.   Multiple Sclerosis Journal

Reversible cerebral vasoconstriction syndrome associated with fingolimod treatment in relapsing–remitting multiple sclerosis three months after childbirth

(2015) Markus Kraemer et al.   Multiple Sclerosis Journal

Multiple sclerosis and pregnancy in the 'treatment era'

(2015) Sandra Vukusic et al.   Nature Reviews Neurology

Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis

(2015) Aaron L Boster et al.   Expert Review of Neurotherapeutics

Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses

(2015) Kerstin Hellwig et al.   JAMA Neurology

Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study

(2015) Maria Sepúlveda et al.   Multiple Sclerosis Journal

Reversible cerebral vasoconstriction syndrome associated with fingolimod treatment in relapsing–remitting multiple sclerosis three months after childbirth

(2015) Markus Kraemer et al.   Multiple Sclerosis Journal

The need for a disease-specific prospective pregnancy registry for multiple sclerosis (MS)

(2015) Sura Alwan et al.   Multiple Sclerosis and Related Disorders

Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study

(2014) Chiara Pecori et al.   BMC Neurology

Pregnancy in Multiple Sclerosis

(2014) Kerstin Hellwig   EUROPEAN NEUROLOGY

Glatiramer acetate to treat multiple sclerosis during pregnancy and lactation: a safety evaluation

(2014) Yara Dadalti Fragoso   Expert Opinion On Drug Safety

Serum anti-Müllerian hormone levels in reproductive-age women with relapsing–remitting multiple sclerosis

(2014) Jan Thöne et al.   Multiple Sclerosis Journal

Parity is associated with a longer time to reach irreversible disability milestones in women with multiple sclerosis

(2014) S Masera et al.   Multiple Sclerosis Journal

Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study

(2014) Neda Ebrahimi et al.   Multiple Sclerosis Journal

MS disease activity in RESTORE: A randomized 24-week natalizumab treatment interruption study

(2014) R. J. Fox et al.   NEUROLOGY

Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis

(2014) G. Karlsson et al.   NEUROLOGY

Management of Multiple Sclerosis During Pregnancy and the Reproductive Years

(2014) Riley Bove et al.   OBSTETRICS AND GYNECOLOGY

Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events

(2014) P K Coyle et al.   BMJ Open

One can prevent post-partum MS relapses by exclusive breast feeding: Yes

(2013) Annette Langer-Gould et al.   Multiple Sclerosis Journal

One can prevent post-partum MS relapses by exclusive breast feeding: No

(2013) Sandra Vukusic et al.   Multiple Sclerosis Journal

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

(2013) Ashley H Beecham et al.   NATURE GENETICS

Sex and gender issues in multiple sclerosis

(2013) Hanne F. Harbo et al.   Therapeutic Advances in Neurological Disorders

Breastfeeding and multiple sclerosis relapses: a meta-analysis

(2012) Julia Pakpoor et al.   JOURNAL OF NEUROLOGY

Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review

(2012) E. Lu et al.   NEUROLOGY

Multiple sclerosis and pregnancy: experience from a nationwide database in Germany

(2012) Kerstin Hellwig et al.   Therapeutic Advances in Neurological Disorders

Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis

(2011) M. B. D’hooghe et al.   JOURNAL OF NEUROLOGY

Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment

(2011) Kerstin Hellwig et al.   Multiple Sclerosis Journal

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis

(2011) P. W. O'Connor et al.   NEUROLOGY

Reversible cerebral vasoconstriction syndrome: an under-recognized clinical emergency

(2010) Shih-Pin Chen et al.   Therapeutic Advances in Neurological Disorders

Gender and sex hormones in multiple sclerosis pathology and therapy

(2009) Arnaud Nicot   Frontiers in Bioscience-Landmark

Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study

(2009) C Weber-Schoendorfer et al.   Multiple Sclerosis Journal

Immunomodulation and postpartum relapses in patients with multiple sclerosis

(2009) Kerstin Hellwig et al.   Therapeutic Advances in Neurological Disorders